Pub Date : 2024-05-07DOI: 10.1186/s12992-023-01012-w
Greg Lyle, Delia Hendrie
Background: In response to the harm caused by tobacco use worldwide, the World Health Organization (WHO) World Health Assembly actioned the WHO Framework Convention on Tobacco Control (FCTC) in 2005. To help countries meet their FCTC obligations, the WHO introduced in 2008 the MPOWER policy package and by 2020 the FCTC had been ratified by 182 parties. The package consists of six evidence-based demand reduction smoking cessation policies to assist countries to achieve best practice. We used published evaluation results and replicated the published model to estimate current policy achievement and demonstrate the impact and equity of the MPOWER policy package in reducing the global number of smokers and smoking-attributable deaths (SADs) between 2007 and 2020.
Methods: We replicated an evaluation model (the Abridged SimSmoke model) used previously for country impact assessments and validated our replicated reduction in SADs for policies between 2014 and 2016 against the published results. The replicated model was then applied to report on the country level SADs averted from achieving the highest level of implementation, that is best practice in MPOWER policies, between 2016 and 2020. The latest results were then combined with past published results to estimate the reduction in SADs since the commencement of the MPOWER policy package. Country level income status was used to investigate the equity in the uptake of MPOWER policies worldwide.
Results: Identical estimates for SADs in 41 out of 56 MPOWER policies implemented in 43 countries suggested good agreement in the model replication. The replicated model overestimated the reduction in SADs by 159,800 (1.5%) out of a total of 10.5 million SADs with three countries contributing to the majority of this replication discrepancy. Updated analysis estimated a reduction of 8.57 million smokers and 3.37 million SADs between 2016 and 2020. Between 2007 and 2020, 136 countries had adopted and maintained at least one MPOWER policy at the highest level which was associated with a reduction in 81.0 million smokers and 28.3 million SADs. Seventy five percent of this reduction was in middle income countries, 20% in high income and less than 5% in low income countries.
Conclusions: Considerable progress has been made by MPOWER policies to reduce the prevalence of smokers globally. However, there is inequality in the implementation and maintenance, reach and influence, and the number of SADs averted. Future research to modify the model could provide a more comprehensive evaluation of past and future progress in tobacco control policies, worldwide.
{"title":"Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 2020.","authors":"Greg Lyle, Delia Hendrie","doi":"10.1186/s12992-023-01012-w","DOIUrl":"10.1186/s12992-023-01012-w","url":null,"abstract":"<p><strong>Background: </strong>In response to the harm caused by tobacco use worldwide, the World Health Organization (WHO) World Health Assembly actioned the WHO Framework Convention on Tobacco Control (FCTC) in 2005. To help countries meet their FCTC obligations, the WHO introduced in 2008 the MPOWER policy package and by 2020 the FCTC had been ratified by 182 parties. The package consists of six evidence-based demand reduction smoking cessation policies to assist countries to achieve best practice. We used published evaluation results and replicated the published model to estimate current policy achievement and demonstrate the impact and equity of the MPOWER policy package in reducing the global number of smokers and smoking-attributable deaths (SADs) between 2007 and 2020.</p><p><strong>Methods: </strong>We replicated an evaluation model (the Abridged SimSmoke model) used previously for country impact assessments and validated our replicated reduction in SADs for policies between 2014 and 2016 against the published results. The replicated model was then applied to report on the country level SADs averted from achieving the highest level of implementation, that is best practice in MPOWER policies, between 2016 and 2020. The latest results were then combined with past published results to estimate the reduction in SADs since the commencement of the MPOWER policy package. Country level income status was used to investigate the equity in the uptake of MPOWER policies worldwide.</p><p><strong>Results: </strong>Identical estimates for SADs in 41 out of 56 MPOWER policies implemented in 43 countries suggested good agreement in the model replication. The replicated model overestimated the reduction in SADs by 159,800 (1.5%) out of a total of 10.5 million SADs with three countries contributing to the majority of this replication discrepancy. Updated analysis estimated a reduction of 8.57 million smokers and 3.37 million SADs between 2016 and 2020. Between 2007 and 2020, 136 countries had adopted and maintained at least one MPOWER policy at the highest level which was associated with a reduction in 81.0 million smokers and 28.3 million SADs. Seventy five percent of this reduction was in middle income countries, 20% in high income and less than 5% in low income countries.</p><p><strong>Conclusions: </strong>Considerable progress has been made by MPOWER policies to reduce the prevalence of smokers globally. However, there is inequality in the implementation and maintenance, reach and influence, and the number of SADs averted. Future research to modify the model could provide a more comprehensive evaluation of past and future progress in tobacco control policies, worldwide.</p>","PeriodicalId":12747,"journal":{"name":"Globalization and Health","volume":"20 1","pages":"40"},"PeriodicalIF":10.8,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140876260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: As a recognized win-win-win approach to international debt relief, Debt-to-Health(D2H)has successfully translated debt repayments into investments in health-related projects. Although D2H has experienced modifications and periodic suspension, it has been playing an increasingly important role in resource mobilization in public health, particularly for low-and middle-income countries deep in debt.
Main text: D2H, as a practical health financing instrument, is not fully evidenced and gauged by academic literature though. We employed a five-step scoping review methodology. After posing questions, we conducted comprehensive literature searches across three databases and one official website to identify relevant studies.We also supplemented our research with expert interviews. Through this review and interviews, we were able to define the concept and structure of D2H, identify stakeholders, and assess its current shortcomings. Finally, we proposed relevant countermeasures and suggestions.
Conclusion: This paper examines the D2H project's implementation structure and influencing variables, as well as the current research plan's limitations, with a focus on the role health funding institutions have played during the project's whole life. Simultaneously, it examines the interdependencies between debtor nations, creditor nations, and health financing establishments, establishing the groundwork for augmenting and revamping D2H within the ever-changing worldwide context of health development assistance.
{"title":"Redefining Debt-to-Health, a triple-win health financing instrument in global health.","authors":"Yunxuan Hu, Zhebin Wang, Shuduo Zhou, Jian Yang, Ying Chen, Yumeng Wang, Ming Xu","doi":"10.1186/s12992-024-01043-x","DOIUrl":"10.1186/s12992-024-01043-x","url":null,"abstract":"<p><strong>Background: </strong>As a recognized win-win-win approach to international debt relief, Debt-to-Health(D2H)has successfully translated debt repayments into investments in health-related projects. Although D2H has experienced modifications and periodic suspension, it has been playing an increasingly important role in resource mobilization in public health, particularly for low-and middle-income countries deep in debt.</p><p><strong>Main text: </strong>D2H, as a practical health financing instrument, is not fully evidenced and gauged by academic literature though. We employed a five-step scoping review methodology. After posing questions, we conducted comprehensive literature searches across three databases and one official website to identify relevant studies.We also supplemented our research with expert interviews. Through this review and interviews, we were able to define the concept and structure of D2H, identify stakeholders, and assess its current shortcomings. Finally, we proposed relevant countermeasures and suggestions.</p><p><strong>Conclusion: </strong>This paper examines the D2H project's implementation structure and influencing variables, as well as the current research plan's limitations, with a focus on the role health funding institutions have played during the project's whole life. Simultaneously, it examines the interdependencies between debtor nations, creditor nations, and health financing establishments, establishing the groundwork for augmenting and revamping D2H within the ever-changing worldwide context of health development assistance.</p>","PeriodicalId":12747,"journal":{"name":"Globalization and Health","volume":"20 1","pages":"39"},"PeriodicalIF":10.8,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11071208/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140851073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-06DOI: 10.1186/s12992-024-01048-6
Lijuan Yang
Background: The COVID-19 pandemic has highlighted the importance of designing effective trade recovery measures in response to global health events (GHEs). This study combines international trade risk management theory and multi-case comparative analysis of past GHEs to present a theoretical framework for designing national trade recovery measures for future events.
Results: The research finds that during GHEs, trade risks shift to fundamental uncertainty, requiring spatial-temporal-subject dimension recovery measures. The study suggests changing the focus of trade recovery policy design from emergency-oriented and single-dimension measures to reserve-oriented and enduring-effect measures of comprehensive dimensions at micro- and macroeconomic levels.
Conclusion: The study contributes to the debate on managing trade risks in times of crisis, where there is a need to develop effective trade recovery measures that account for the complexities of global trade and the unique challenges of GHEs. The findings provide practical guidance for trade officials and policymakers to design measures in response to GHEs to improve a country's overall trade recovery.
背景:COVID-19 大流行凸显了针对全球健康事件 (GHE) 设计有效贸易恢复措施的重要性。本研究结合国际贸易风险管理理论和对以往全球卫生事件的多案例比较分析,提出了为未来事件设计国家贸易恢复措施的理论框架:研究发现,在 GHE 期间,贸易风险转向基本不确定性,需要采取空间-时间-主体维度的恢复措施。研究建议将贸易恢复政策设计的重点从以应急为导向的单一维度措施转变为以储备为导向、在微观和宏观经济层面采取综合维度的持久效应措施:本研究有助于就危机时期的贸易风险管理展开讨论,因为危机时期需要制定有效的贸易恢复措施,以应对全球贸易的复杂性和全球温室气体的独特挑战。研究结果为贸易官员和政策制定者提供了切实可行的指导,帮助他们制定应对全球经济危机的措施,从而改善国家的整体贸易复苏状况。
{"title":"From isolation to revival: trade recovery amid global health crises.","authors":"Lijuan Yang","doi":"10.1186/s12992-024-01048-6","DOIUrl":"10.1186/s12992-024-01048-6","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic has highlighted the importance of designing effective trade recovery measures in response to global health events (GHEs). This study combines international trade risk management theory and multi-case comparative analysis of past GHEs to present a theoretical framework for designing national trade recovery measures for future events.</p><p><strong>Results: </strong>The research finds that during GHEs, trade risks shift to fundamental uncertainty, requiring spatial-temporal-subject dimension recovery measures. The study suggests changing the focus of trade recovery policy design from emergency-oriented and single-dimension measures to reserve-oriented and enduring-effect measures of comprehensive dimensions at micro- and macroeconomic levels.</p><p><strong>Conclusion: </strong>The study contributes to the debate on managing trade risks in times of crisis, where there is a need to develop effective trade recovery measures that account for the complexities of global trade and the unique challenges of GHEs. The findings provide practical guidance for trade officials and policymakers to design measures in response to GHEs to improve a country's overall trade recovery.</p>","PeriodicalId":12747,"journal":{"name":"Globalization and Health","volume":"20 1","pages":"38"},"PeriodicalIF":10.8,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11071179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140861800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-03DOI: 10.1186/s12992-024-01040-0
Amir Hossein Khoshakhlagh, Mahdiyeh Mohammadzadeh, Agnieszka Gruszecka-Kosowska, Evangelos Oikonomou
Cardiovascular diseases (CVDs) are estimated to be the leading cause of global death. Air pollution is the biggest environmental threat to public health worldwide. It is considered a potentially modifiable environmental risk factor for CVDs because it can be prevented by adopting the right national and international policies. The present study was conducted to synthesize the results of existing studies on the burden of CVDs attributed to air pollution, namely prevalence, hospitalization, disability, mortality, and cost characteristics. A systematic search was performed in the Scopus, PubMed, and Web of Science databases to identify studies, without time limitations, up to June 13, 2023. Exclusion criteria included prenatal exposure, exposure to indoor air pollution, review studies, conferences, books, letters to editors, and animal and laboratory studies. The quality of the articles was evaluated based on the Agency for Healthcare Research and Quality Assessment Form, the Newcastle–Ottawa Scale, and Drummond Criteria using a self-established scale. The articles that achieved categories A and B were included in the study. Of the 566 studies obtained, based on the inclusion/exclusion criteria, 92 studies were defined as eligible in the present systematic review. The results of these investigations supported that chronic exposure to various concentrations of air pollutants, increased the prevalence, hospitalization, disability, mortality, and costs of CVDs attributed to air pollution, even at relatively low levels. According to the results, the main pollutant investigated closely associated with hypertension was PM2.5. Furthermore, the global DALY related to stroke during 2016–2019 has increased by 1.8 times and hospitalization related to CVDs in 2023 has increased by 8.5 times compared to 2014. Ambient air pollution is an underestimated but significant and modifiable contributor to CVDs burden and public health costs. This should not only be considered an environmental problem but also as an important risk factor for a significant increase in CVD cases and mortality. The findings of the systematic review highlighted the opportunity to apply more preventive measures in the public health sector to reduce the footprint of CVDs in human society.
据估计,心血管疾病(CVD)是导致全球死亡的主要原因。空气污染是全球公共健康面临的最大环境威胁。空气污染被认为是心血管疾病潜在的可改变的环境风险因素,因为它可以通过采取正确的国家和国际政策来预防。本研究旨在综合现有关于空气污染导致心血管疾病负担的研究结果,即发病率、住院率、残疾率、死亡率和成本特征。本研究在 Scopus、PubMed 和 Web of Science 数据库中进行了系统检索,以确定截至 2023 年 6 月 13 日的无时间限制的研究。排除标准包括产前暴露、室内空气污染暴露、综述研究、会议、书籍、致编辑的信以及动物和实验室研究。文章的质量根据医疗保健研究与质量机构评估表、纽卡斯尔-渥太华量表和德拉蒙德标准进行评估,采用的是自制的量表。达到 A 类和 B 类标准的文章被纳入研究范围。在获得的 566 项研究中,根据纳入/排除标准,有 92 项研究被界定为符合本系统综述的要求。这些调查结果表明,长期暴露于各种浓度的空气污染物,会增加心血管疾病的发病率、住院率、残疾率、死亡率和成本,即使在相对较低的水平上也是如此。调查结果显示,与高血压密切相关的主要污染物是 PM2.5。此外,与 2014 年相比,2016-2019 年期间与中风有关的全球残疾调整寿命年数增加了 1.8 倍,2023 年与心血管疾病有关的住院治疗增加了 8.5 倍。环境空气污染是造成心血管疾病负担和公共卫生成本的一个被低估但可改变的重要因素。这不仅是一个环境问题,也是心血管疾病病例和死亡率大幅增加的重要风险因素。系统综述的研究结果强调了在公共卫生部门采取更多预防措施的机会,以减少心血管疾病在人类社会中的足迹。
{"title":"Burden of cardiovascular disease attributed to air pollution: a systematic review","authors":"Amir Hossein Khoshakhlagh, Mahdiyeh Mohammadzadeh, Agnieszka Gruszecka-Kosowska, Evangelos Oikonomou","doi":"10.1186/s12992-024-01040-0","DOIUrl":"https://doi.org/10.1186/s12992-024-01040-0","url":null,"abstract":"Cardiovascular diseases (CVDs) are estimated to be the leading cause of global death. Air pollution is the biggest environmental threat to public health worldwide. It is considered a potentially modifiable environmental risk factor for CVDs because it can be prevented by adopting the right national and international policies. The present study was conducted to synthesize the results of existing studies on the burden of CVDs attributed to air pollution, namely prevalence, hospitalization, disability, mortality, and cost characteristics. A systematic search was performed in the Scopus, PubMed, and Web of Science databases to identify studies, without time limitations, up to June 13, 2023. Exclusion criteria included prenatal exposure, exposure to indoor air pollution, review studies, conferences, books, letters to editors, and animal and laboratory studies. The quality of the articles was evaluated based on the Agency for Healthcare Research and Quality Assessment Form, the Newcastle–Ottawa Scale, and Drummond Criteria using a self-established scale. The articles that achieved categories A and B were included in the study. Of the 566 studies obtained, based on the inclusion/exclusion criteria, 92 studies were defined as eligible in the present systematic review. The results of these investigations supported that chronic exposure to various concentrations of air pollutants, increased the prevalence, hospitalization, disability, mortality, and costs of CVDs attributed to air pollution, even at relatively low levels. According to the results, the main pollutant investigated closely associated with hypertension was PM2.5. Furthermore, the global DALY related to stroke during 2016–2019 has increased by 1.8 times and hospitalization related to CVDs in 2023 has increased by 8.5 times compared to 2014. Ambient air pollution is an underestimated but significant and modifiable contributor to CVDs burden and public health costs. This should not only be considered an environmental problem but also as an important risk factor for a significant increase in CVD cases and mortality. The findings of the systematic review highlighted the opportunity to apply more preventive measures in the public health sector to reduce the footprint of CVDs in human society.","PeriodicalId":12747,"journal":{"name":"Globalization and Health","volume":"6 1","pages":""},"PeriodicalIF":10.8,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140828711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-19DOI: 10.1186/s12992-024-01031-1
Duncan Stewart, Mary Madden, Jim McCambridge
Alcohol problems are increasing across the world and becoming more complex. Limitations to international evidence and practice mean that the screening and brief intervention paradigm forged in the 1980s is no longer fit for the purpose of informing how conversations about alcohol should take place in healthcare and other services. A new paradigm for brief interventions has been called for. We must start with a re-appraisal of the roles of alcohol in society now and the damage it does to individual and population health. Industry marketing and older unresolved ideas about alcohol continue to impede honest and thoughtful conversations and perpetuate stigma, stereotypes, and outright fictions. This makes it harder to think about and talk about how alcohol affects health, well-being, and other aspects of life, and how we as a society should respond. To progress, brief interventions should not be restricted only to the self-regulation of one’s own drinking. Content can be orientated to the properties of the drug itself and the overlooked problems it causes, the policy issues and the politics of a powerful globalised industry. This entails challenging and reframing stigmatising notions of alcohol problems, and incorporating wider alcohol policy measures and issues that are relevant to how people think about their own and others' drinking. We draw on recent empirical work to examine the implications of this agenda for practitioners and for changing the public conversation on alcohol. Against a backdrop of continued financial pressures on health service delivery, this analysis provokes debate and invites new thinking on alcohol. We suggest that the case for advancing brief interventions version 2.0 is both compelling and urgent.
{"title":"Brief interventions 2.0: a new agenda for alcohol policy, practice and research","authors":"Duncan Stewart, Mary Madden, Jim McCambridge","doi":"10.1186/s12992-024-01031-1","DOIUrl":"https://doi.org/10.1186/s12992-024-01031-1","url":null,"abstract":"Alcohol problems are increasing across the world and becoming more complex. Limitations to international evidence and practice mean that the screening and brief intervention paradigm forged in the 1980s is no longer fit for the purpose of informing how conversations about alcohol should take place in healthcare and other services. A new paradigm for brief interventions has been called for. We must start with a re-appraisal of the roles of alcohol in society now and the damage it does to individual and population health. Industry marketing and older unresolved ideas about alcohol continue to impede honest and thoughtful conversations and perpetuate stigma, stereotypes, and outright fictions. This makes it harder to think about and talk about how alcohol affects health, well-being, and other aspects of life, and how we as a society should respond. To progress, brief interventions should not be restricted only to the self-regulation of one’s own drinking. Content can be orientated to the properties of the drug itself and the overlooked problems it causes, the policy issues and the politics of a powerful globalised industry. This entails challenging and reframing stigmatising notions of alcohol problems, and incorporating wider alcohol policy measures and issues that are relevant to how people think about their own and others' drinking. We draw on recent empirical work to examine the implications of this agenda for practitioners and for changing the public conversation on alcohol. Against a backdrop of continued financial pressures on health service delivery, this analysis provokes debate and invites new thinking on alcohol. We suggest that the case for advancing brief interventions version 2.0 is both compelling and urgent.","PeriodicalId":12747,"journal":{"name":"Globalization and Health","volume":"13 1","pages":""},"PeriodicalIF":10.8,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140628730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-18DOI: 10.1186/s12992-024-01038-8
Alessandro Connor Crocetti, Troy Walker, Fiona Mitchell, Simone Sherriff, Karen Hill, Yin Paradies, Kathryn Backholer, Jennifer Browne
The commercial determinants of health is a rapidly expanding field of research; however Indigenous perspectives remain notably underrepresented. For Indigenous peoples the intersection of globalisation, colonialism and capitalism may amplify commercially-driven health inequities. This study aimed to explore the perspectives of Aboriginal leaders regarding the influence of commercial activities on Aboriginal health and wellbeing in Victoria, Australia. Semi-structured interviews with 23 Aboriginal leaders from across five sectors (n = 15 urban, n = 8 rural/regional) were analysed through reflexive thematic analysis. Three overarching themes were identified encompassing (i) harmful commercial practices and processes, (ii) improving corporate engagement and (iii) opportunities for self-determination through business. Participants expressed concern over aggressive marketing by the gambling industry, commercial exploitation of Aboriginal culture, the privatisation of public services, and lack of oversignt of corporate social responsibility strategies. Simultaneously, Aboriginal-led businesses were viewed as opportunities for cultural connection, and financial empowerment and self-determination. Numerous commercial entities and activities are perceived to influence Aboriginal health and wellbeing. This study highlights the need for stronger policy and regulation to mitigate harmful industry practices while incentivising the potential positive impacts of the commercial activities on Aboriginal health and wellbeing.
{"title":"Making Big Business Everybody’s Business: Aboriginal leaders’ perspectives on commercial activities influencing aboriginal health in Victoria, Australia","authors":"Alessandro Connor Crocetti, Troy Walker, Fiona Mitchell, Simone Sherriff, Karen Hill, Yin Paradies, Kathryn Backholer, Jennifer Browne","doi":"10.1186/s12992-024-01038-8","DOIUrl":"https://doi.org/10.1186/s12992-024-01038-8","url":null,"abstract":"The commercial determinants of health is a rapidly expanding field of research; however Indigenous perspectives remain notably underrepresented. For Indigenous peoples the intersection of globalisation, colonialism and capitalism may amplify commercially-driven health inequities. This study aimed to explore the perspectives of Aboriginal leaders regarding the influence of commercial activities on Aboriginal health and wellbeing in Victoria, Australia. Semi-structured interviews with 23 Aboriginal leaders from across five sectors (n = 15 urban, n = 8 rural/regional) were analysed through reflexive thematic analysis. Three overarching themes were identified encompassing (i) harmful commercial practices and processes, (ii) improving corporate engagement and (iii) opportunities for self-determination through business. Participants expressed concern over aggressive marketing by the gambling industry, commercial exploitation of Aboriginal culture, the privatisation of public services, and lack of oversignt of corporate social responsibility strategies. Simultaneously, Aboriginal-led businesses were viewed as opportunities for cultural connection, and financial empowerment and self-determination. Numerous commercial entities and activities are perceived to influence Aboriginal health and wellbeing. This study highlights the need for stronger policy and regulation to mitigate harmful industry practices while incentivising the potential positive impacts of the commercial activities on Aboriginal health and wellbeing.","PeriodicalId":12747,"journal":{"name":"Globalization and Health","volume":"40 1","pages":""},"PeriodicalIF":10.8,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140617762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-16DOI: 10.1186/s12992-024-01036-w
Julia Anaf, Toby Freeman, Fran Baum
Historically in Australia, all levels of government created collective wealth by owning and operating infrastructure, and managing natural assets, key public goods and essential services while being answerable to the public. This strong state tradition was challenged in the 1980s when privatisation became a widespread government approach globally. Privatisation involves displacing the public sector through modes of financing, ownership, management and product or service delivery. The Australian literature shows that negative effects from privatisation are not spread equitably, and the health and equity impacts appear to be under-researched. This narrative overview aims to address a gap in the literature by answering research questions on what evidence exists for positive and negative outcomes of privatisation; how well societal impacts are evaluated, and the implications for health and equity. Database and grey literature were searched by keywords, with inclusion criteria of items limited to Australia, published between 1990 and 2022, relating to any industry or government sector, including an evaluative aspect, or identifying positive or negative aspects from privatisation, contracting out, or outsourcing. Thematic analysis was aided by NVivo qualitative data software and guided by an a-priori coding frame. No items explicitly reflected on the relationship between privatisation and health. Main themes identified were the public cost of privatisation, loss of government control and expertise, lack of accountability and transparency, constraints to accessing social determinants of health, and benefits accruing to the private sector. Our results supported the view that privatisation is more than asset-stripping the public sector. It is a comprehensive strategy for restructuring public services in the interests of capital, with privatisation therefore both a political and commercial determinant of health. There is growing discussion on the need for re-nationalisation of certain public assets, including by the Victorian government. Privatisation of public services is likely to have had an adverse impact on population health and contributed to the increase in inequities. This review suggests that there is little evidence for the benefits of privatisation, with a need for greater attention to political and commercial determinants of health in policy formation and in research.
{"title":"Privatisation of government services in Australia: what is known about health and equity impacts","authors":"Julia Anaf, Toby Freeman, Fran Baum","doi":"10.1186/s12992-024-01036-w","DOIUrl":"https://doi.org/10.1186/s12992-024-01036-w","url":null,"abstract":"Historically in Australia, all levels of government created collective wealth by owning and operating infrastructure, and managing natural assets, key public goods and essential services while being answerable to the public. This strong state tradition was challenged in the 1980s when privatisation became a widespread government approach globally. Privatisation involves displacing the public sector through modes of financing, ownership, management and product or service delivery. The Australian literature shows that negative effects from privatisation are not spread equitably, and the health and equity impacts appear to be under-researched. This narrative overview aims to address a gap in the literature by answering research questions on what evidence exists for positive and negative outcomes of privatisation; how well societal impacts are evaluated, and the implications for health and equity. Database and grey literature were searched by keywords, with inclusion criteria of items limited to Australia, published between 1990 and 2022, relating to any industry or government sector, including an evaluative aspect, or identifying positive or negative aspects from privatisation, contracting out, or outsourcing. Thematic analysis was aided by NVivo qualitative data software and guided by an a-priori coding frame. No items explicitly reflected on the relationship between privatisation and health. Main themes identified were the public cost of privatisation, loss of government control and expertise, lack of accountability and transparency, constraints to accessing social determinants of health, and benefits accruing to the private sector. Our results supported the view that privatisation is more than asset-stripping the public sector. It is a comprehensive strategy for restructuring public services in the interests of capital, with privatisation therefore both a political and commercial determinant of health. There is growing discussion on the need for re-nationalisation of certain public assets, including by the Victorian government. Privatisation of public services is likely to have had an adverse impact on population health and contributed to the increase in inequities. This review suggests that there is little evidence for the benefits of privatisation, with a need for greater attention to political and commercial determinants of health in policy formation and in research.","PeriodicalId":12747,"journal":{"name":"Globalization and Health","volume":"72 1","pages":""},"PeriodicalIF":10.8,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140602732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-15DOI: 10.1186/s12992-024-01035-x
Xue-Fang Yao
On July 4, 2021, China officially introduced the drug patent linkage system, which has made more localized adjustments than have similar systems in the US and South Korea. This study describes the characteristics and outcomes of China’s patent linkage system. For this study, we used the database of China’s patent information registration platform for marketed drugs to capture all listed patents and patent certifications from June 25, 2021, to June 30, 2023. We used descriptive statistics for the above data to assess the impact of patent linkage on branded drug manufacturers, generic drug manufacturers, and the public’s access to medicines. During the study period, the patents of 632 branded drugs were listed, and 5058 ANDAs submitted patent certifications to the Registration Platform. Of these 632 branded drugs, 462 (73.1%) drugs were approved before the year of patent registration, and the average number of listed patents per drug was 1.8, with a standard deviation of 1.4. However, of these 5058 ANDAs, P1 certifications accounted for 85.1%, and P3 and P4 certifications accounted for 16% combined. In addition, according to the detailed statistics of P2 certifications, we found that the proportion of patent invalidation cases was 46.4%. The remaining validity of the patents corresponding to P3 certifications was longer, with a median value of 17 months, and the IQR was 10-30.75, ranging from − 2 to 204 months. China’s patent linkage aims to promote the balance of multiple interests —innovation, imitation and public health—and has its own system characteristics. Patent listing and patent certification are the key indicators reflecting the implementation effect of the system. From the perspective of system outcomes, ANDAs have been connected to the patent linkage system in an orderly manner, but the growth of patent challenges is not obvious. Moreover, manufacturers of foreign branded drugs that have not yet entered the Chinese market need to pay more attention to the role of patent listing.
{"title":"Characteristics and outcomes of the drug patent linkage system in China","authors":"Xue-Fang Yao","doi":"10.1186/s12992-024-01035-x","DOIUrl":"https://doi.org/10.1186/s12992-024-01035-x","url":null,"abstract":"On July 4, 2021, China officially introduced the drug patent linkage system, which has made more localized adjustments than have similar systems in the US and South Korea. This study describes the characteristics and outcomes of China’s patent linkage system. For this study, we used the database of China’s patent information registration platform for marketed drugs to capture all listed patents and patent certifications from June 25, 2021, to June 30, 2023. We used descriptive statistics for the above data to assess the impact of patent linkage on branded drug manufacturers, generic drug manufacturers, and the public’s access to medicines. During the study period, the patents of 632 branded drugs were listed, and 5058 ANDAs submitted patent certifications to the Registration Platform. Of these 632 branded drugs, 462 (73.1%) drugs were approved before the year of patent registration, and the average number of listed patents per drug was 1.8, with a standard deviation of 1.4. However, of these 5058 ANDAs, P1 certifications accounted for 85.1%, and P3 and P4 certifications accounted for 16% combined. In addition, according to the detailed statistics of P2 certifications, we found that the proportion of patent invalidation cases was 46.4%. The remaining validity of the patents corresponding to P3 certifications was longer, with a median value of 17 months, and the IQR was 10-30.75, ranging from − 2 to 204 months. China’s patent linkage aims to promote the balance of multiple interests —innovation, imitation and public health—and has its own system characteristics. Patent listing and patent certification are the key indicators reflecting the implementation effect of the system. From the perspective of system outcomes, ANDAs have been connected to the patent linkage system in an orderly manner, but the growth of patent challenges is not obvious. Moreover, manufacturers of foreign branded drugs that have not yet entered the Chinese market need to pay more attention to the role of patent listing.","PeriodicalId":12747,"journal":{"name":"Globalization and Health","volume":"51 1","pages":""},"PeriodicalIF":10.8,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140589024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-12DOI: 10.1186/s12992-024-01037-9
Kevin K. C. Hung, Makiko K. MacDermot, Theresa S. I. Hui, Suet Yi Chan, Sonoe Mashino, Catherine P. Y. Mok, Pak Ho Leung, Ryoma Kayano, Jonathan Abrahams, Chi Shing Wong, Emily Y. Y. Chan, Colin A. Graham
<p><b>Globalization and Health (2024) 20:15</b></p><p>https://doi.org/10.1186/s12992-023-01010-y</p><p>Following publication of the original article, it was brought to the journal's attention that the article had published with the wrong license: it had published with the Creative Commons Attribution 4.0 International License, whereas the correct license is the Creative Commons Attribution 3.0 IGO License. The license has been corrected in the published article. The publisher thanks you for reading this erratum and apologizes for any inconvenience caused.</p><h3>Authors and Affiliations</h3><ol><li><p>Accident and Emergency Medicine Academic Unit, Trauma & Emergency Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, New Territories, Shatin, Hong Kong</p><p>Kevin K. C. Hung, Makiko K. MacDermot, Theresa S. I. Hui, Suet Yi Chan, Catherine P. Y. Mok, Pak Ho Leung, Emily Y. Y. Chan & Colin A. Graham</p></li><li><p>Collaborating Centre for Oxford University, JC School of Public Health and Primary Care, Chinese University of Hong Kong for Disaster and Medical Humanitarian Response (CCOUC), The Chinese University of Hong Kong, Shatin, Hong Kong, China</p><p>Kevin K. C. Hung, Chi Shing Wong, Emily Y. Y. Chan & Colin A. Graham</p></li><li><p>Research Institute of Nursing Care for People and Community, University of Hyogo, 673-8588, Akashi, Japan</p><p>Sonoe Mashino</p></li><li><p>World Health Organization, Centre for Health Development, 651-0073, Kobe, Japan</p><p>Ryoma Kayano</p></li><li><p>Disaster Resilience Initiative, Monash University, Monash University, Clayton, Australia</p><p>Jonathan Abrahams</p></li></ol><span>Authors</span><ol><li><span>Kevin K. C. Hung</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Makiko K. MacDermot</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Theresa S. I. Hui</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Suet Yi Chan</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Sonoe Mashino</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Catherine P. Y. Mok</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Pak Ho Leung</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Ryoma Kayano</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Jonathan Abrahams</span>View author publications<p>You can also sear
全球化与健康》(2024)20:15https://doi.org/10.1186/s12992-023-01010-yFollowing,在发表原文时,本刊注意到文章使用了错误的许可协议:文章使用的是知识共享署名 4.0 国际许可协议,而正确的许可协议是知识共享署名 3.0 IGO 许可协议。已发布文章中的许可协议已更正。出版商感谢您阅读此勘误,并对造成的不便深表歉意。作者及所属单位香港中文大学威尔斯亲王医院急症中心意外及急症医学学术组、创伤及门诊部香港中文大學牛津大學、公共衛生及基層醫療學院、香港中文大學災難及人道主義醫療應變合作中心(CCOUC),香港中文大學,中國香港沙田Kevin K. C. Hung, Chi Shing Wong, Emily Y. Y. Chan & Colin A. GrahamResearch Institute of Nursing Care Services, The Chinese University of Hong Kong, Shatin, Hong Kong, ChinaKevin K. C. Hung, Chi Shing Wong, Emily Y. Y. Chan & Colin A. GrahamResearch Institute of Nursing Care Services, The Chinese University of Hong Kong, Shatin, Hong Kong.GrahamResearch Institute of Nursing Care for People and Community, University of Hyogo, 673-8588, Akashi, JapanSonoe MashinoWorld Health Organization, Centre for Health Development, 651-0073, Kobe, JapanRyoma KayanoDisaster Resilience Initiative, Monash University, Monash University, Clayton, AustraliaJonathan AbrahamsAuthorsKevin K. C. HungView author publications您也可以在PubMed Google ScholarMakiko K. MacDermot中搜索该作者。MacDermotView 作者发表作品您也可以在PubMed Google Scholar中搜索该作者Theresa S. I. HuiView 作者发表作品您也可以在PubMed Google Scholar中搜索该作者Suet Yi ChanView 作者发表作品您也可以在PubMed Google Scholar中搜索该作者Sonoe MashinoView 作者发表作品您也可以在PubMed Google Scholar中搜索该作者Catherine P. Y. Mok查看作者发表作品Y.MokView作者发表论文您也可以在PubMed Google Scholar中搜索该作者Pak Ho LeungView作者发表论文您也可以在PubMed Google Scholar中搜索该作者Ryoma KayanoView作者发表论文您也可以在PubMed Google Scholar中搜索该作者Jonathan AbrahamsView作者发表论文您也可以在PubMed Google Scholar中搜索该作者Chi Shing WongView作者发表论文您也可以在PubMed Google Scholar中搜索该作者Emily Y. Y. ChanView作者发表论文您也可以在PubMed Google Scholar中搜索该作者Emily Y. Y. ChanView作者发表论文您也可以在PubMed Google Scholar中搜索该作者Emily Y. Y.Y.ChanView作者发表的作品您也可以在PubMed Google Scholar中搜索该作者Colin A. GrahamView作者发表的作品您也可以在PubMed Google Scholar中搜索该作者Corresponding authorCorrespondence to Colin A. Graham.Graham.Publisher'sNoteSpringerNature对已出版地图中的管辖权主张和机构隶属关系保持中立。原文的在线版本可在https://doi.org/10.1186/s12992-023-01010-y.Open Access本文采用知识共享署名 4.0 国际许可协议进行许可,该协议允许以任何媒介或格式使用、共享、改编、分发和复制,只要您适当注明原作者和来源,提供知识共享许可协议的链接,并说明是否进行了修改。本文中的图片或其他第三方材料均包含在文章的知识共享许可协议中,除非在材料的署名栏中另有说明。如果材料未包含在文章的知识共享许可协议中,且您打算使用的材料不符合法律规定或超出许可使用范围,则您需要直接从版权所有者处获得许可。要查看该许可的副本,请访问 http://creativecommons.org/licenses/by/4.0/。除非在数据的信用行中另有说明,否则知识共享公共领域专用免责声明 (http://creativecommons.org/publicdomain/zero/1.0/) 适用于本文提供的数据。转载与许可引用本文Hung, K.K.C., MacDermot, M.K., Hui, T.S.I. et al. Correction:卫生应急与灾害风险管理能力和课程的绘图研究:文献综述和横断面调查。Global Health 20, 30 (2024). https://doi.org/10.1186/s12992-024-01037-9Download citationPublished: 12 April 2024DOI: https://doi.org/10.1186/s12992-024-01037-9Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative
{"title":"Correction: Mapping study for health emergency and disaster risk management competencies and curricula: literature review and cross-sectional survey","authors":"Kevin K. C. Hung, Makiko K. MacDermot, Theresa S. I. Hui, Suet Yi Chan, Sonoe Mashino, Catherine P. Y. Mok, Pak Ho Leung, Ryoma Kayano, Jonathan Abrahams, Chi Shing Wong, Emily Y. Y. Chan, Colin A. Graham","doi":"10.1186/s12992-024-01037-9","DOIUrl":"https://doi.org/10.1186/s12992-024-01037-9","url":null,"abstract":"<p><b>Globalization and Health (2024) 20:15</b></p><p>https://doi.org/10.1186/s12992-023-01010-y</p><p>Following publication of the original article, it was brought to the journal's attention that the article had published with the wrong license: it had published with the Creative Commons Attribution 4.0 International License, whereas the correct license is the Creative Commons Attribution 3.0 IGO License. The license has been corrected in the published article. The publisher thanks you for reading this erratum and apologizes for any inconvenience caused.</p><h3>Authors and Affiliations</h3><ol><li><p>Accident and Emergency Medicine Academic Unit, Trauma & Emergency Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, New Territories, Shatin, Hong Kong</p><p>Kevin K. C. Hung, Makiko K. MacDermot, Theresa S. I. Hui, Suet Yi Chan, Catherine P. Y. Mok, Pak Ho Leung, Emily Y. Y. Chan & Colin A. Graham</p></li><li><p>Collaborating Centre for Oxford University, JC School of Public Health and Primary Care, Chinese University of Hong Kong for Disaster and Medical Humanitarian Response (CCOUC), The Chinese University of Hong Kong, Shatin, Hong Kong, China</p><p>Kevin K. C. Hung, Chi Shing Wong, Emily Y. Y. Chan & Colin A. Graham</p></li><li><p>Research Institute of Nursing Care for People and Community, University of Hyogo, 673-8588, Akashi, Japan</p><p>Sonoe Mashino</p></li><li><p>World Health Organization, Centre for Health Development, 651-0073, Kobe, Japan</p><p>Ryoma Kayano</p></li><li><p>Disaster Resilience Initiative, Monash University, Monash University, Clayton, Australia</p><p>Jonathan Abrahams</p></li></ol><span>Authors</span><ol><li><span>Kevin K. C. Hung</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Makiko K. MacDermot</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Theresa S. I. Hui</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Suet Yi Chan</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Sonoe Mashino</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Catherine P. Y. Mok</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Pak Ho Leung</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Ryoma Kayano</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Jonathan Abrahams</span>View author publications<p>You can also sear","PeriodicalId":12747,"journal":{"name":"Globalization and Health","volume":"96 1","pages":""},"PeriodicalIF":10.8,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140589026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-12DOI: 10.1186/s12992-024-01033-z
Martha Carnalla, Nancy López-Olmedo, Yenisei Ramírez-Toscano, Luz Mery Cárdenas-Cárdenas, Francisco Canto-Osorio, Herney Rengifo-Reina, David Barrera-Núñez, Josúe Alai Quiroz-Reyes, M. Arantxa Colchero, Tonatiuh Barrientos-Gutiérrez
The association between environmental temperature and alcohol consumption has not been widely explored despite the potential that increasing temperatures could promote the consumption of alcoholic beverages and the alcohol-related burden of disease. We aimed to explore the association between temperature and binge drinking in Mexican adults from urban cities, overall, and by alcoholic beverage type. Data on 10,552 adults ≥ 18 years was obtained from the 2016 National Survey on Drug, Alcohol, and Tobacco Consumption. The mean annual temperature at the municipality was obtained from the Mexican National Weather Service using monthly temperatures from 2015 to 2016. We analyzed binge drinking for all alcoholic beverages in the last year and by type of alcohol as beer, liquor, wine, and coolers. Associations between mean temperature over the past year and binge drinking over the past year among current drinkers were estimated using multilevel Poisson models with robust standard errors adjusted for age, sex, education level, marital status, and household socioeconomic status, with a fixed effect by region. We observed a non-significant increase in the prevalence of binge drinking for every difference of 1 °C between municipalities of the same region. By alcohol type, a 1 °C increase in mean annual temperature across municipalities of the same region increased the prevalence of beer binge drinking in the past year by 0.9% (PR = 1.009, 95%CI 1.005, 1.013) among beer consumers and the prevalence of coolers’ binge drinking by 3.0% (PR = 1.030, 95%CI 1.003, 1.057) in coolers consumers. We observed non-significant results for liquor binge drinking (PR = 1.047, 95%CI 0.994, 1.102) and wine binge drinking (PR = 1.047, 95% 0.944, 1.161). People living in municipalities with higher temperatures reported a higher beer binge drinking in Mexican cities. This could account for 196,000 cases of beer binge drinking in 2016. The context of each country needs to be considered when generalizing these findings, and they need to be further explored with longitudinal data as there might be implications for climate change. If our findings are confirmed given the forecasted rising temperatures, we could expect an increase in binge drinking and therefore, in the alcohol burden of disease.
{"title":"Binge drinking associated with mean temperature: a cross-sectional study among Mexican adults living in cities","authors":"Martha Carnalla, Nancy López-Olmedo, Yenisei Ramírez-Toscano, Luz Mery Cárdenas-Cárdenas, Francisco Canto-Osorio, Herney Rengifo-Reina, David Barrera-Núñez, Josúe Alai Quiroz-Reyes, M. Arantxa Colchero, Tonatiuh Barrientos-Gutiérrez","doi":"10.1186/s12992-024-01033-z","DOIUrl":"https://doi.org/10.1186/s12992-024-01033-z","url":null,"abstract":"The association between environmental temperature and alcohol consumption has not been widely explored despite the potential that increasing temperatures could promote the consumption of alcoholic beverages and the alcohol-related burden of disease. We aimed to explore the association between temperature and binge drinking in Mexican adults from urban cities, overall, and by alcoholic beverage type. Data on 10,552 adults ≥ 18 years was obtained from the 2016 National Survey on Drug, Alcohol, and Tobacco Consumption. The mean annual temperature at the municipality was obtained from the Mexican National Weather Service using monthly temperatures from 2015 to 2016. We analyzed binge drinking for all alcoholic beverages in the last year and by type of alcohol as beer, liquor, wine, and coolers. Associations between mean temperature over the past year and binge drinking over the past year among current drinkers were estimated using multilevel Poisson models with robust standard errors adjusted for age, sex, education level, marital status, and household socioeconomic status, with a fixed effect by region. We observed a non-significant increase in the prevalence of binge drinking for every difference of 1 °C between municipalities of the same region. By alcohol type, a 1 °C increase in mean annual temperature across municipalities of the same region increased the prevalence of beer binge drinking in the past year by 0.9% (PR = 1.009, 95%CI 1.005, 1.013) among beer consumers and the prevalence of coolers’ binge drinking by 3.0% (PR = 1.030, 95%CI 1.003, 1.057) in coolers consumers. We observed non-significant results for liquor binge drinking (PR = 1.047, 95%CI 0.994, 1.102) and wine binge drinking (PR = 1.047, 95% 0.944, 1.161). People living in municipalities with higher temperatures reported a higher beer binge drinking in Mexican cities. This could account for 196,000 cases of beer binge drinking in 2016. The context of each country needs to be considered when generalizing these findings, and they need to be further explored with longitudinal data as there might be implications for climate change. If our findings are confirmed given the forecasted rising temperatures, we could expect an increase in binge drinking and therefore, in the alcohol burden of disease.","PeriodicalId":12747,"journal":{"name":"Globalization and Health","volume":"197 1","pages":""},"PeriodicalIF":10.8,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140588849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}